How uncontrolled inflammation leads to brain cell loss



Recently, those researchers conducted a study that investigated the mechanisms that regulate inflammation in the brain, what happens when they stop working properly, and why that may happen. The cannabinoid receptor type 1 (CB1), they say, plays an important role in processing the "rush" sensation produced by cannabis. It also appears to be involved in the regulation of inflammatory reactions in the brain. If CB1 receptors fail to respond, this contributes to the development of chronic inflammation, which can eventually lead to the loss of brain cells. So reports the study paper, now published in the journal Frontiers in Molecular Neuroscience.

Brake signals for inflammation

The researchers say that the immune response in the brain is mounted via microglial cells, a type of specialized immune cell found in the central nervous system, which includes the brain and the spinal chord. Microglia work by responding to bacteria and clearing out malfunctioning nerve cells. At the same time, they send signals to recruit other types of immune cells and trigger inflammation when needed. However, if unregulated, an inflammatory reaction in the brain can misguidedly attack and damage healthy brain tissue."We know that so-called endocannabinoids play an important role in this," explains study co-author Dr Andras Bilkei-Gorzo. "[Endocannabinoids]," he goes on, "are messenger substances produced by the body that acts as a kind of brake signal: [t]hey prevent the inflammatory activity of the glial cells."These messenger substances act by binding to certain receptors, one of which is CB1. A second one is a cannabinoid receptor type 2 (CB2). Microglial cells have low levels of CB2, and even less, or no, CB1, the researchers explain. Still, these immune cells will react to endocannabinoids despite this lack.


Comments

Post a Comment

Popular posts from this blog

The Genetic Landscape of Cerebral Steno-Occlusive Arteriopathy and Stroke in Sickle Cell Anemia.

Image
Sickle cell disease (SCD) is one of the most common autosomal recessive diseases in humans, occurring at a frequency of 1 in 365 African-American and 1 in 50 sub-Saharan African births. Despite progress in managing complications of SCD, these remain a major health burden worldwide. Stroke is a common and serious complication of SCD, most often associated with steno-occlusive cerebral arteriopathy, but little is known about its pathogenesis. Transcranial Doppler ultrasonography is currently the only predictive test for the future development of stroke in patients with sickle cell anemia and is used to guide preventative treatment. However, transcranial Doppler ultrasonography does not identify all patients at increased risk for stroke, and progressive arteriopathy may occur despite preventative treatment. While sibling studies have shown a strong genetic contribution to the development of steno-occlusive arteriopathy (SOA) in SCD, the only genome-wide association study
Read more

Does Variability of Brain Blood Flow Increase Stroke Risk in Stroke Survivors and After TIA?

Image
Stroke is the second leading cause of death worldwide, and high blood pressure (BP) is the most important treatable factor that increases a person’s risk of having a stroke. Stiffness of the blood vessels supplying the brain (arterial stiffness), possibly due to long-standing raised BP, is also likely to be a factor that increases stroke risk. Such increased arterial stiffness results in the blood flow through these vessels being more pulsatile (throbs faster) than usual, and this increased pulsatility can be assessed by an ultrasound scan. This research is focused on assessing the relationship between the pulsatility of the blood flow through the blood vessels supplying the brain, and the risk of stroke in patients who have already had a stroke or “mini-stroke” in the past, and in particular to see if this relationship can be explained by raised BP alone. The Oxford Vascular Study (OXVASC) recruits all patients with stroke or “ mini-stroke ” from a single population,
Read more

Vitamin D and hypertension

Image
Vitamin D, a fat-soluble prohormone, has wide-ranging roles in the regulation of many physiological processes through their interactions with the vitamin D receptors (VDR). It plays a major role in bones and calcium metabolism. Vitamin D deficiency is not uncommon and it has been associated with many health-related issues, including skeletal and non-skeletal complications. The association of low vitamin D and cardiovascular diseases and risk factors has been explored in both animal and human studies. However, studies and trials on the effect of vitamin D supplementation on cardiovascular risk factors and hypertension are conflicting with inconsistent results. Therefore, large, well-powered randomized controlled trials are warranted. If successful, supplementation with easy and low-cost vitamin D can impact our health positively. Here, we summarized the evidence for the association of vitamin D, cardiovascular diseases and risk factors, including coronary artery diseases,
Read more